Patents by Inventor Anders Björk
Anders Björk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11896564Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, for use in combination with a 5-ASA agent, in the treatment of a disease resulting from pathologic inflammation. The combination of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof and 5-ASA agent and use of such combination. A kit-of-parts and a pharmaceutical composition comprising such a combination.Type: GrantFiled: August 15, 2019Date of Patent: February 13, 2024Assignee: PHARMACYL ABInventors: Gunnar Hedlund, Anders Björk
-
Patent number: 11717500Abstract: A method for the treatment a disease resulting from spondyloarthritis, such as axial spondyloarthritis, psoriatic arthritis and enteropathic arthritis, by administering, to a mammal in need of such treatment, a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof.Type: GrantFiled: January 26, 2021Date of Patent: August 8, 2023Assignee: PHARMACYL ABInventors: Anders Björk, Gunnar Hedlund
-
Publication number: 20220087959Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, for use in combination with a 5-ASA agent, in the treatment of a disease resulting from pathologic inflammation. The combination of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof and 5-ASA agent and use of such combination. A kit-of-parts and a pharmaceutical composition comprising such a combination.Type: ApplicationFiled: August 15, 2019Publication date: March 24, 2022Inventors: Gunnar HEDLUND, Anders BJÖRK
-
Publication number: 20210299071Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition comprising the compound. The compound is useful for the treatment a disease resulting from pathologic inflammation, such as inflammatory bowel disease, psoriasis or rheumatoid arthritis.Type: ApplicationFiled: August 15, 2019Publication date: September 30, 2021Inventors: Anders BJÖRK, Gunnar HEDLUND
-
Publication number: 20210236441Abstract: A method for the treatment a disease resulting from spondyloarthritis, such as axial spondyloarthritis, psoriatic arthritis and enteropathic arthritis, by administering, to a mammal in need of such treatment, a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof.Type: ApplicationFiled: January 26, 2021Publication date: August 5, 2021Inventors: Anders BJÖRK, Gunnar HEDLUND
-
Patent number: 8434424Abstract: A method for milking animals in a milking station (9) including a milking machine (14) for milking said animals, and a first feeding device (21) for feeding said animals intermittently or continuously with feed, is disclosed, the method comprising the steps of allowing a milking animal to enter the milking station (9); feeding the milking animal in the milking station intermittently or continuously with feed by means of the first feeding device (21); and milking the milking animal in the milking station (9) by means of the milking machine (14). According to the present invention, the feeding of the milking animal is terminated at a non-final stage of the milking in order to secure that the milking animal has terminated to consume the feed when the milking is finished.Type: GrantFiled: March 17, 2005Date of Patent: May 7, 2013Assignee: DeLaval Holding ABInventors: Anders Björk, Gunnar Pettersson
-
Patent number: 8314124Abstract: A stable solid pharmaceutical composition consisting essentially of an effective amount of a crystalline salt of formula (II) together with an alkaline-reacting component maintaining the pH preferably above 8, or a salt with a divalent metal cation; and at least one pharmaceutical excipient; said salt of formula (II) being essentially stable during storage at room temperature for a period of at least 3 years. A process for stabilizing the salt of formula (II). A crystalline salt of formula (II) and a process for preparing said salt.Type: GrantFiled: March 17, 2009Date of Patent: November 20, 2012Assignee: Active Biotech ABInventors: Karl Jansson, Tomas Fristedt, Hans Wännman, Anders Björk
-
Patent number: 7589208Abstract: A stable solid pharmaceutical composition consisting essentially of an effective amount of a salt of formula (II) together with an alkaline-reacting component maintaining the pH preferably above 8, or a salt with a divalent metal cation; and at least one pharmaceutical excipient; said salt of formula (II) being essentially stable during storage at room temperature for a period of at least 3 years. A process for stabilizing the salt of formula (II). A crystalline salt of formula (II) and a process for preparing said salt.Type: GrantFiled: February 4, 2005Date of Patent: September 15, 2009Assignee: Active Biotech ABInventors: Karl Jansson, Tomas Fristedt, Hans Wännman, Anders Björk
-
Patent number: 7553849Abstract: A compound of formula (I) wherein R is methyl, ethyl, n-propyl, iso-propyl, n-butyl or allyl; R? is hydrogen, C1-C4 alkyl, C1-C3 alkoxy; halogen, trifluoromethyl or OCHxFy, R? is hydrogen, fluoro or chloro, that R? being fluoro or chloro only when R? is fluoro or chloro; R3 is hydrogen or C1-C5 alkyl R4 is hydrogen, CH2OCOC(CH3)3, pharmaceutically acceptable inorganic or organic cations, or COR4? wherein R4? is C1-C5 alkyl, phenyl, benzyl or phenethyl; R7 is methyl or ethyl; one of A and B is sulphur and the other is C-R2; when A is S, R2 is selected from hydrogen and methyl, with the proviso that R2 is methyl only when R3 is not hydrogen; and when B is S, R2 is hydrogen; and any tautomer thereof. A pharmaceutical composition comprising a compound of formula (I), a method of treating malignant tumours or diseases resulting from autoimmunity or pathologic inflammation.Type: GrantFiled: June 15, 2005Date of Patent: June 30, 2009Assignee: Active Biotech ABInventors: Anders Björk, Karl Jansson
-
Patent number: 7511143Abstract: A stable solid pharmaceutical composition consisting essentially of an effective amount of a salt of formula (II) together with an alkaline-reacting component maintaining the pH preferably above 8, or a salt with a divalent metal cation; and at least one pharmaceutical excipient; said salt of formula (II) being essentially stable during storage at room temperature for a period of at least 3 years. A process for stabilizing the salt of formula (II). A crystalline salt of formula (II) and a process for preparing said salt.Type: GrantFiled: February 4, 2005Date of Patent: March 31, 2009Assignee: Active Biotech ABInventors: Karl Jansson, Tomas Fristedt, Hans Wännman, Anders Björk
-
Publication number: 20080109266Abstract: A method includes the steps of recording milk yields (MY?1#191, MY?2#191, MY?N#191) from milkings of an udder quarter or udder of a milking animal; recording the times (t1, t2, . . . , tN) of the milkings; calculating milk secretion rates (MSR1, MSR2, . . . , MSRN) for said udder quarter or udder based on the milk yields and times; fitting a time dependent function (F(t)) to the calculated secretion rates, said time dependent function comprising one portion, which increases with time, and one portion, which decreases with time; estimating an expected milk secretion rate (EMSRt1+N) for said udder quarter or udder at a time (tN+1) following the last milking based on said function (F(t)); determining an expected milk yield (EMYtN+1) for said udder quarter or udder at said time based on the expected secretion rate and, at said time, the time period lapsed since last milking; and initiating an action to be performed with respect to said animal depending on said expected milk yield.Type: ApplicationFiled: May 12, 2004Publication date: May 8, 2008Applicant: DELAVAL HOLDING ABInventors: Anders Björk, Susanne Granz
-
Patent number: 7311479Abstract: The present invention relates to a tool as well as a blank for manufacturing of the tool. The tool is made of solid cemented carbide and includes a shank for mounting in a rotatable spindle and chip flutes. Lines of intersection between the chip flutes and clearance surfaces form cutting edges at a cutting end of the tool. The flush channels extend through the entire tool in order to transfer flushing medium to the cutting end of the tool. The flush channels have varying pitch.Type: GrantFiled: December 5, 2005Date of Patent: December 25, 2007Assignee: Seco Tools ABInventors: Johnny Bruhn, Mattias Puide, Mattias Svensson, Anders Björk, Jimmy Karlsson, Mikael Grönqvist
-
Patent number: 7128020Abstract: This invention relates to a device and a method for allowing performance of several separate treatment of a teat of an animal. The device includes a cup-shaped body (1) having a surface (2) defining an inner space (3), which is arranged to receive the teat of the animal. The device also includes a first delivery mechanism arranged to provide a first treatment by supplying a first medium (4) to the teat via at least a first passage having a plurality of openings (10, 18) to the inner space (3) and at least one additional delivery mechanism arranged to provide an additional medium (13, 26, 28) to the teat, via at least an additional passage having a plurality of openings (10,18) to the inner space(3). Thereby, the device provides at least two different treatments of the teats at different occasions.Type: GrantFiled: October 10, 2002Date of Patent: October 31, 2006Assignee: Delaval Holding ABInventors: Anders Björk, Gösta Forsén, Bohao Liao
-
Patent number: 6769261Abstract: A system for controlling the cooling of small milk quantities in a cooling tank (4). An agitation pipe (2) extended through a regular milk outlet (26) in a first end wall (6) of the tank is provided, having a nozzle end (32) for introducing incoming/re-circulated milk onto a milk cooling surface (14) at a predetermined position (dp). The position (dp) being situated (1) between a first end wall (6) and a central part of the tank (4) and laterally displaced (b) relative to the perpendicular central axis of the tank. The nozzle end (32) is directed towards a second end wall (8) of the tank (4). Agitation is performed by the agitation pipe (2) upon demand or when the milk quantity is insufficient for a regular agitator element (27) to work properly.Type: GrantFiled: September 29, 2003Date of Patent: August 3, 2004Assignee: DeLaval Holding ABInventors: Mats Gustavsson, Anders Björk, Magnus Lidman
-
Patent number: 6605616Abstract: The invention is related to compounds of general formula (I) wherein R is methyl, ethyl, n-propyl, iso-propyl, n-butyl or allyl; R′ is methyl, methoxy, fluoro, chloro, bromo, azido, trifluorometlhyl, or OCHxFy, wherein x=0−2, y=1−3 with the. proviso that x+y=3; R″ is hydrogen, fluoro or chloro; with the proviso that R″ is fluoro or chloro only when R′ is fluoro or chloro; R4 is hydrogen or pharmaceutically acceptable inorganic or organic cations; R5 is dimethylamino or nitro; R6 is hydrogen; and when R′ is azido R5 is also ethyl, n-propyl, iso-propyl, methoxy, ethoxy, chloro, bromo, trifluoromethyl, OCHxFy, wherein x=0−2, y=1−3 with the proviso that x+y=3, or R5 and R6 taken together are methylenedioxy; and any tautomer thereof. The invention also relates to pharmaceutical compositions containing a compound of the general formula (I) together with a pharmaceutically acceptable carrier.Type: GrantFiled: July 21, 2000Date of Patent: August 12, 2003Assignee: Active Biotech ABInventors: Anders Björk, Stig Jönsson, Tomas Fex, Gunnar Hedlund
-
Patent number: 6593343Abstract: Compounds of formula (I) and tautomers thereof are effective for the treatment of mammals suffering from diseases resulting from autoimmunity and pathological inflammation.Type: GrantFiled: April 25, 2002Date of Patent: July 15, 2003Assignee: Active Biotech ABInventors: Anders Björk, Stig Jönsson, Tomas Fex, Gunnar Hedlund
-
Patent number: 6425345Abstract: A method and device for milking an animal by using at least one milking machine (5) including at least one teatcup (3) having a teatcup liner (11) forming a space defined by a wall surface. The teatcup (3) is arranged to be applied to a teat in such a manner that the wall surface extends around and abuts the teat. The device includes a control unit arranged to control the application of the teatcup (3) in such a manner that an arbitrary portion of the wall surface abuts different teat portions during a first milking occasion with respect to an animal and during a later milking occasion with respect to this animal, respectively.Type: GrantFiled: August 18, 2000Date of Patent: July 30, 2002Assignee: Delaval Holding ABInventors: Ole Lind, Anders Björk
-
Patent number: 6395750Abstract: The invention relates to a method for the treatment of tumors in mammals by the administration of compounds of the general formula (I) wherein A is O41 or NR42 R43 wherein R41 is hydrogen or a pharmaceutically acceptable inorganic or organic cation, or CORA wherein RA is alkyl and aryl; R42 and R43 are hydrogen, C1-C4-alkyl, cyclopropyl, cyclopentyl or cyclohexyl; or R42 is benzyl or phenethyl, optionally mono- or disubstituted by methyl, iso-propyl methoxy, fluoro, chloro, bromo, dimethylamino, trifluoromethyl or nitro and R43 is hydrogen; or R42 and R43 form a 5- or 6-membered ring; or R42 is CORB wherein RB is alkyl or aryl, —CH2N(CH3)2 or —CH2CH2COOH or CORB is a 2-acyloxymethylbenzoyl group wherein RC is methyl, ethyl, phenyl or benzyl; R42 is COORD wherein RD is C1-C4-alkyl, phenyl or benzyl; or R42 is —CH2OCO-tert.Type: GrantFiled: October 24, 2000Date of Patent: May 28, 2002Assignee: Active Biotech ABInventors: Gunnar Hedlund, Karl Jansson, Stig Jönsson, Anders Björk
-
Patent number: 6221858Abstract: Use of a compound of formula (I) and the pharmaceutically acceptable acid addition salts thereof, wherein R1 is either halogen or hydrogen and R2 is halogen; X is CH2, O or S; R3 and R4 are the same or different and selected from hydrogen or lower alkyl; n is 2 or 3; A is selected from the pyrimidyl- or pyridyl-groups (a), (b) or (c) wherein R5, R6 and R7 are as defined in the description; for the manufacture of a medicament for the relief or prevention of a withdrawal syndrome resulting from addiction to a drug or substance of abuse or for treatment thereof.Type: GrantFiled: November 5, 1998Date of Patent: April 24, 2001Assignee: Pharmacia & Upjohn ABInventor: Anders Björk